Speculatively, we believe that the differences in the association of CGM‐derived metrics with MASLD among adults and adolescents with T1DM might be due to some factors, such as diabetes duration, prevalence of MASLD, prevalence of overweight/obesity and time of exposure to insulin therapy. This evidence concerns the gene INS and Obesity.